Immutep Ltd. Files SEC Form 6-K
Ticker: PRRUF · Form: 6-K · Filed: Sep 24, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Sep 24, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $3.6 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, reporting
Related Tickers: IMMP
TL;DR
Immutep (IMMP) filed a routine 6-K with the SEC today, no major news.
AI Summary
Immutep Ltd. announced on September 24, 2024, that it has filed a Form 6-K with the SEC. This filing is a report of a foreign private issuer and does not contain specific financial or operational updates beyond the filing itself. The company previously operated under the name Prima BioMed Ltd. before changing its name on November 19, 2010.
Why It Matters
This filing indicates Immutep Ltd. is fulfilling its reporting obligations as a foreign private issuer with the SEC, which is standard practice for companies with securities traded in the US.
Risk Assessment
Risk Level: low — The filing is a standard procedural report for a foreign private issuer and does not contain new material information that would inherently increase risk.
Key Players & Entities
- IMMUTEP Ltd (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- September 24, 2024 (date) — Filing date
- 001-35428 (other) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country or that it furnishes or is required to furnish to its security holders.
When was Immutep Ltd. previously known by another name?
Immutep Ltd. was formerly known as Prima BioMed Ltd., with the name change occurring on November 19, 2010.
What is Immutep Ltd.'s principal executive office address?
Immutep Ltd.'s principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
Does this Form 6-K filing contain specific financial results or operational updates?
Based on the provided text, this Form 6-K appears to be a procedural filing and does not detail specific financial results or operational updates.
What is Immutep Ltd.'s SIC code?
Immutep Ltd.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 256 words · 1 min read · ~1 pages · Grade level 15.5 · Accepted 2024-09-24 06:06:57
Key Financial Figures
- $3.6 million — on of Exhibit 99.1 Immutep Receives A$3.6 million R&D Tax Incentive from French Governmen
Filing Documents
- d896577d6k.htm (6-K) — 9KB
- d896577dex991.htm (EX-99.1) — 5KB
- g896577dsp1aa.jpg (GRAPHIC) — 11KB
- 0001193125-24-224073.txt ( ) — 30KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: September 24, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer